• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Patterns in admission delays to outpatient methadone treatment in the United States.美国门诊美沙酮治疗入院延迟的模式。
J Subst Abuse Treat. 2011 Dec;41(4):431-9. doi: 10.1016/j.jsat.2011.06.005. Epub 2011 Aug 6.
2
Responses among substance abuse treatment providers to the opioid epidemic in the USA: Variations in buprenorphine and methadone treatment by geography, operational, and payment characteristics, 2007-16.美国阿片类药物泛滥背景下药物滥用治疗提供者的反应:2007-2016 年,按地理位置、运营和支付特征划分的丁丙诺啡和美沙酮治疗的差异。
PLoS One. 2020 Mar 3;15(3):e0229787. doi: 10.1371/journal.pone.0229787. eCollection 2020.
3
Access to treatment for opioid dependence in rural America: challenges and future directions.美国农村地区阿片类药物依赖治疗的可及性:挑战与未来方向。
JAMA Psychiatry. 2014 Apr;71(4):359-60. doi: 10.1001/jamapsychiatry.2013.4450.
4
Racial and Ethnic Disparities in Take-Home Methadone Use for Medicare Beneficiaries With Opioid Use Disorder.患有阿片类物质使用障碍的医疗保险受益人的美沙酮带回家使用情况中的种族和族裔差异。
JAMA Netw Open. 2024 Aug 1;7(8):e2431620. doi: 10.1001/jamanetworkopen.2024.31620.
5
Risk Factors for Relapse and Higher Costs Among Medicaid Members with Opioid Dependence or Abuse: Opioid Agonists, Comorbidities, and Treatment History.医疗补助计划中患有阿片类药物依赖或滥用的成员复发及更高成本的风险因素:阿片类激动剂、合并症和治疗史
J Subst Abuse Treat. 2015 Oct;57:75-80. doi: 10.1016/j.jsat.2015.05.001. Epub 2015 May 7.
6
Methadone Access for Opioid Use Disorder During the COVID-19 Pandemic Within the United States and Canada.美沙酮获取用于治疗阿片类药物使用障碍在新冠大流行期间的美国和加拿大。
JAMA Netw Open. 2021 Jul 1;4(7):e2118223. doi: 10.1001/jamanetworkopen.2021.18223.
7
A trial of implementation facilitation to increase timely admission to methadone treatment.一项实施促进措施以增加美沙酮治疗及时入院的试验。
J Subst Use Addict Treat. 2024 Jul;162:209375. doi: 10.1016/j.josat.2024.209375. Epub 2024 Apr 19.
8
Comparative Effectiveness of Different Treatment Pathways for Opioid Use Disorder.不同阿片类药物使用障碍治疗途径的疗效比较。
JAMA Netw Open. 2020 Feb 5;3(2):e1920622. doi: 10.1001/jamanetworkopen.2019.20622.
9
Antecedents and correlates of methadone treatment entry: a comparison of out-of-treatment and in-treatment cohorts.美沙酮治疗进入的前因和相关因素:治疗前和治疗中队列的比较。
Drug Alcohol Depend. 2011 May 1;115(1-2):23-9. doi: 10.1016/j.drugalcdep.2010.10.016. Epub 2010 Dec 3.
10
Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.阿片类药物成瘾的药物辅助康复:历史和当代视角。
J Addict Dis. 2012;31(3):199-206. doi: 10.1080/10550887.2012.694597.

引用本文的文献

1
Study protocol for a randomized controlled trial to adapt a posttraumatic stress disorder intervention of patients with opioid-stimulant polysubstance use receiving methadone maintenance treatment.一项随机对照试验的研究方案,该试验旨在调整一种针对接受美沙酮维持治疗的阿片类药物 - 兴奋剂多物质使用者的创伤后应激障碍干预措施。
BMC Psychiatry. 2024 Dec 4;24(1):879. doi: 10.1186/s12888-024-06348-0.
2
Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.在假设情况下,治疗阿片类药物使用障碍的美沙酮供应不足,突显了获得药物治疗的空间不平等。
PLoS Comput Biol. 2024 Jul 26;20(7):e1012307. doi: 10.1371/journal.pcbi.1012307. eCollection 2024 Jul.
3
Mobile addiction treatment and harm reduction services as tools to address health inequities: a community case study of the Brockton Neighborhood Health Center mobile unit.移动成瘾治疗和减少伤害服务作为解决健康不平等问题的工具:布罗克顿社区健康中心流动单位的社区案例研究。
Front Public Health. 2024 Jun 18;12:1407522. doi: 10.3389/fpubh.2024.1407522. eCollection 2024.
4
Methadone Treatment Gap in Tennessee and How Medication Units Could Bridge the Gap: A Review.田纳西州的美沙酮治疗缺口以及药物治疗单位如何填补这一缺口:一项综述
Pharmacy (Basel). 2023 Aug 22;11(5):131. doi: 10.3390/pharmacy11050131.
5
Typology of laws restricting access to methadone treatment in the United States: A latent class analysis.美国限制美沙酮治疗准入法律的类型学:潜在类别分析。
Int J Drug Policy. 2023 Sep;119:104141. doi: 10.1016/j.drugpo.2023.104141. Epub 2023 Aug 2.
6
Correlates of Perceived Discrimination Related to Substance Use Disorders Among Patients in Methadone Maintenance Treatment.美沙酮维持治疗患者感知到的与物质使用障碍相关的歧视的相关因素。
J Psychoactive Drugs. 2024 Sep-Oct;56(4):530-540. doi: 10.1080/02791072.2023.2230571. Epub 2023 Jul 3.
7
Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.在阿片类药物使用障碍治疗药物获取方面的空间不平等凸显了在反事实情景下美沙酮提供者的稀缺。
medRxiv. 2023 Nov 8:2023.05.12.23289915. doi: 10.1101/2023.05.12.23289915.
8
History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder.丁丙诺啡药物用于治疗阿片类物质使用障碍的发现、研发及美国食品药品监督管理局批准历程。
Drug Alcohol Depend Rep. 2023 Jan 10;6:100133. doi: 10.1016/j.dadr.2023.100133. eCollection 2023 Mar.
9
Group-based medical mistrust and care expectations among black patients seeking addiction treatment.寻求成瘾治疗的黑人患者群体中基于群体的医疗不信任和护理期望。
Drug Alcohol Depend Rep. 2022 Jan 18;2:100026. doi: 10.1016/j.dadr.2022.100026. eCollection 2022 Mar.
10
Comparative Safety Analysis of Opioid Agonist Treatment in Pregnant Women with Opioid Use Disorder: A Population-Based Study.阿片类物质使用障碍孕妇接受阿片类激动剂治疗的安全性比较:一项基于人群的研究。
Drug Saf. 2023 Mar;46(3):257-271. doi: 10.1007/s40264-022-01267-z. Epub 2023 Jan 16.

本文引用的文献

1
Interim methadone treatment compared to standard methadone treatment: 4-month findings.美沙酮临时治疗与标准美沙酮治疗比较:4 个月的结果。
J Subst Abuse Treat. 2011 Jul;41(1):21-9. doi: 10.1016/j.jsat.2011.01.008. Epub 2011 Feb 24.
2
Buprenorphine implants for treatment of opioid dependence: a randomized controlled trial.丁丙诺啡透皮贴剂治疗阿片类药物依赖的随机对照试验
JAMA. 2010 Oct 13;304(14):1576-83. doi: 10.1001/jama.2010.1427.
3
Impact of interim methadone maintenance on HIV risk behaviors.美沙酮维持治疗的中期效果对 HIV 风险行为的影响。
J Urban Health. 2010 Jul;87(4):586-91. doi: 10.1007/s11524-010-9451-7.
4
Treatment entry among individuals on a waiting list for methadone maintenance.等待美沙酮维持治疗的个体的治疗入组。
Am J Drug Alcohol Abuse. 2009;35(5):290-4. doi: 10.1080/00952990902968577.
5
Interim methadone treatment: impact on arrests.美沙酮临时治疗:对逮捕率的影响。
Drug Alcohol Depend. 2009 Aug 1;103(3):148-54. doi: 10.1016/j.drugalcdep.2009.03.007. Epub 2009 May 14.
6
Evidence for substance abuse services and policy research: a systematic review of national databases.药物滥用服务与政策研究的证据:对国家数据库的系统评价
Eval Rev. 2009 Apr;33(2):103-37. doi: 10.1177/0193841X08328126. Epub 2009 Jan 6.
7
Why don't out-of-treatment individuals enter methadone treatment programmes?为什么脱毒治疗的个体不进入美沙酮维持治疗项目?
Int J Drug Policy. 2010 Jan;21(1):36-42. doi: 10.1016/j.drugpo.2008.07.004. Epub 2008 Sep 20.
8
When can group level clustering be ignored? Multilevel models versus single-level models with sparse data.何时可以忽略群组层面的聚类?多层模型与具有稀疏数据的单层面模型的比较。
J Epidemiol Community Health. 2008 Aug;62(8):752-8. doi: 10.1136/jech.2007.060798.
9
Drug treatment outcomes for persons on waiting lists.等待名单上人员的药物治疗结果。
Am J Drug Alcohol Abuse. 2008;34(5):526-33. doi: 10.1080/00952990802146340.
10
Waiting Time as a Barrier to Treatment Entry: Perceptions of Substance Users.等待时间作为治疗准入的障碍:物质使用者的看法。
J Drug Issues. 2006 Sep;36(4):831-852. doi: 10.1177/002204260603600404.

美国门诊美沙酮治疗入院延迟的模式。

Patterns in admission delays to outpatient methadone treatment in the United States.

机构信息

Friends Research Institute, 1040 Park Avenue, Suite 103, Baltimore MD 21201, USA.

出版信息

J Subst Abuse Treat. 2011 Dec;41(4):431-9. doi: 10.1016/j.jsat.2011.06.005. Epub 2011 Aug 6.

DOI:10.1016/j.jsat.2011.06.005
PMID:21821378
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3205308/
Abstract

Waiting lists for methadone treatment have existed in many U.S. communities, but little is known nationally about what patient and service system factors are related to admission delays that stem from program capacity shortfalls. Using a combination of national data sources, this study examined patterns in capacity-related admission delays to outpatient methadone treatment in 40 U.S. metropolitan areas (N = 28,920). Patient characteristics associated with admission delays included racial/ethnic minority status, lower education, criminal justice referral, prior treatment experience, secondary cocaine or alcohol use, and co-occurring psychiatric problems. Injection drug users experienced fewer delays, as did self-pay patients and referrals from health care and addiction treatment providers. Higher community-level utilization of methadone treatment was associated with delay, whereas delays were less common in communities with higher utilization of alternative modalities. These findings highlight potential disparities in timely admission to outpatient methadone treatment. Implications for improving treatment access and service system monitoring are discussed.

摘要

等候接受美沙酮治疗的名单在美国的许多社区都存在,但全国范围内对于哪些患者和服务系统因素与因项目能力不足而导致的入院延迟有关知之甚少。本研究结合了国家数据源,考察了 40 个美国大都市地区门诊美沙酮治疗相关入院延迟的模式(N=28920)。与入院延迟相关的患者特征包括种族/民族少数群体地位、教育程度较低、刑事司法转介、既往治疗经验、次要可卡因或酒精使用以及同时存在的精神健康问题。注射吸毒者的延迟时间较少,自付患者和来自医疗保健和成瘾治疗提供者的转介也是如此。较高的社区层面的美沙酮治疗利用率与延迟相关,而在替代模式利用率较高的社区,延迟的情况则不太常见。这些发现突出了门诊美沙酮治疗及时入院方面的潜在差异。讨论了改善治疗机会和服务系统监测的意义。